Chairman, President and CEO of Golden Entertainment Inc (NASDAQ:GDEN) Blake L Sartini sold 953,506 shares of GDEN on 01/23/2018 at an average price of $26.64 a share. The total sale was $25.4 million.
Golden Entertainment Inc is an US based company which focuses on distributed gaming, casino and resort operations. It organizes its business in two segments; Distributed Gaming and Casinos. Golden Entertainment Inc has a market cap of $812.170 million; its shares were traded at around $30.75 with a P/E ratio of 27.71 and P/S ratio of 1.66.
CEO Recent Trades:
Chairman, President and CEO, 10% Owner Blake L Sartini sold 953,506 shares of GDEN stock on 01/23/2018 at the average price of $26.64. The price of the stock has increased by 15.43% since.
Directors and Officers Recent Trades:
Director Lyle Berman sold 750,000 shares of GDEN stock on 01/23/2018 at the average price of $26.64. The price of the stock has increased by 15.43% since.
For the complete insider trading history of GDEN, click here
Top Casino Stocks To Invest In Right Now: Eli Lilly and Company(LLY)
- [By Johanna Bennett]
Eli Lilly & Co. (LLY) and Biogen (BIIB) are far from the only two drug makers racing to deliver a new treatment for Alzheimers disease. But they are pretty much leading the pack.
The market for an effective therapy that actually slows the progression of the disease would likely generate billions of dollars in annual sales. It is quite literally the drug industrys version of the holy grail.
And according to Barclays analysts Geoff Meacham and Paul Choi, the next few weeks could prove to be one of the most fertile periods in Alzheimers disease research since 2008.
We think the most likely outcome for Lilly’s Phase 3 EXPEDITION 3 (E3) solanezumab trial is the primary cognition (ADAS-Cog14) endpoint is met (just achieving statistical significance with a p-value <0.05) and mixed results on the secondary endpoints including function (ADL), which we believe should be good enough to support a regulatory submission. While aducanumab has a marginally different mechanism of action, we nevertheless expect BIIB shares to trade in sympathy to Lilly.
Implications for Biogen and Merck: The E3 results are likely to result in volatility for Biogen (up 20-30%, down 10-15%) as Alzheimer’s drives both long-term growth and M&A value even though aducanumab works differently from solanezumab.
Aducanumab dose titration data is expected at the CTAD meeting (San Diego, Dec. 9). Merck’s Phase 2/3 EPOCH verubecestat (BACE) trial is scheduled to finish in June 2017 but unlike E3, PET scans/CSF tests for A were not an inclusion criteria. We think Merck shares could move 3% to 5% in either direction in sympathy to E3.
At $76.58, Lillys share price has fallen more than 9% over the past year, while Biogen has climbed more than 9% over the same span.
- [By ]
In the Lightning Round, Cramer was bullish on Spotify (SPOT) , Alkermes (ALKS) , Johnson & Johnson (JNJ) , Thermo Fisher Scientific (TMO) , Sorrento Therapeutics (SRNE) , NVIDIA (NVDA) , Nucor, Eli Lilly (LLY) and Kohlberg Kravis Roberts (KKR) .
- [By WWW.THESTREET.COM]
Bond prices were much lower early in the day, with yields up by nearly 10 basis points. But fixed income has rallied back (reducing the drop by half on the day). Valeant Pharmaceuticals (VRX) , more weakness. Large pharma lower, led by Eli Lilly (LLY) . Old tech lags, with International Business Machines (IBM) , Intel (INTC) , Cisco Systems (CSCO) and Microsoft (MSFT) all lower. Media roughed up a bit (CBS (CBS) and Comcast (CMCSA) ). The Ugly
Gold down another $23 to $1,188 (SPDR Gold Trust ETF (GLD) down $2.25). Urban Outfitters (URBN) down $5. NOTE: There will be no “Takeaways” today! Happy Thanksgiving. Position: Long GLD small, SDS large, JCP large; short SPY, CSCO, CAT small, IWM, TLT small.
- [By Chris Lange]
Eli Lilly & Co. (NYSE: LLY) saw its shares in free fall on Wednesday, not from the usual rhetoric of politicians or even the election, for that matter, but a late-stage trial failure. As 24/7 Wall St. has said time and again, clinical trials can make or break biotech and pharma companies. In this case Eli Lilly hit new 52-week lows, not seen since 2014 and this will not be a loss that Eli Lilly will easily forget. Effectively, the company announced results from its Phase 3 solanezumab trial in people with mild dementia due to Alzheimers disease (AD).
- [By ]
AbbVie (ABBV) : “I want to stay away from controversy. I like Eli Lilly (LLY) .”
Cramer and the AAP team note that seven of the companies in their portfolio are reporting this week, including Abbott Laboratories (ABT) , Nucor (NUE) and Honeywell (HON) . Find out what they’re telling their investment club members and get in on the conversation with a free trial subscription to Action Alerts PLUS.
Top Casino Stocks To Invest In Right Now: Oriental Financial Group Inc.(OFG)
- [By Peter Graham]
Small cap OFG Bancorp (NYSE: OFG) is a diversified financial holding company that operates under U.S. and Puerto Rico banking laws and regulations. Its three principal subsidiaries, Oriental Bank, Oriental Financial Services and Oriental Insurance, provide a full range of commercial, consumer and mortgage banking services, as well as financial planning, trust, insurance, investment brokerage and investment banking services, primarily in Puerto Rico, through 48 financial centers.
Top Casino Stocks To Invest In Right Now: Potash Corporation of Saskatchewan Inc.(POT)
- [By Ben Levisohn]
We also want to reiterate our bullish view on the agricultural commodities and the ag-related stocks (e.g., CF Industries Holdings (CF), Mosaic (MOS), Potash Corp. of Saskatchewan (POT), FMC (FMC), AGCO, Deere). Following sharp multi-year declines, trends continue to improve.
- [By Shanthi Rexaline]
Agri-Input Companies — Seeds/ Fertilizers/Pesticides Manufacturers
Monsanto Company (NYSE: MON): +68.82 percent since 2011. Syngenta AG (ADR) (NYSE: SYT): +56.26 percent since 2011. Mosaic Co (NYSE: MOS): -63.1 percent since 2011. Potash Corporation of Saskatchewan (USA) (NYSE: POT): -67.8 percent since 2011. CF Industries Holdings, Inc. (NYSE: CF): +5.04 percent since 2011. Agrium Inc. (USA) (NYSE: AGU): +1.10 percent since 2011.
Top Casino Stocks To Invest In Right Now: Daiichi Sankyo Company, Limited (DSKYF)
- [By SEEKINGALPHA.COM]
According to Bob Radie (see transcript of January 9th teleconference), the company’s president and chief executive officer, a key consideration in the denial was the FDA’s granting, in November 2016, rival product MorphaBond three-year exclusivity for the intranasal route of abuse. Significantly, though, even though MorphaBond – developed by tiny, privately-owned Inspirion Delivery Technologies – was approved in October 2015, it is yet to be commercialized. An October 25, 2016, marketing agreement between Inspirion and Japan-based Daiichi Sankyo, Inc. (OTCPK:DSKYF) suggests MorphaBond could be launched in the near future, but it’s also important to note that the aforementioned exclusivity expires on October 2, 2018, at which point Egalet will be able to include the clinical data from its intranasal abuse potential study in its label.
Top Casino Stocks To Invest In Right Now: Franco-Nevada Corporation(FNV)
- [By Alex McGuire]
This list ranks gold dividend stocks in the mining sector by dividend yield. And it also includes one of our top gold stock recommendations of 2017…
Gold Dividend Stock Share Price Year-to-Date Performance Dividend Yield (as of June 30)
DRDGOLD Ltd. (NYSE ADR: DRD) $3.19 -39.7% 10.24%
Sibanye Gold Ltd. (NYSE ADR: SBGL) $4.70 -33.4% 5.98%
Harmony Gold Mining Co. (NYSE ADR: HMY) $1.62 -26.7% 4.56%
Gold Fields Limited (NYSE ADR: GFI) $3.41 +13.3% 2.73%
Randgold Resources Ltd. (Nasdaq ADR: GOLD) $87.68 +14.9% 1.89%
Franco Nevada Corp. (NYSE: FNV) $72.39 +21.1% 1.27%
Royal Gold Inc. (Nasdaq: RGLD) $76.85 +21.3% 1.25%
Eldorado Gold Corp. (NYSE: EGO) $2.58 -19.9% 1.16%
Barrick Gold Corp. (NYSE: ABX) $15.90 -0.5% 0.75%
Goldcorp Inc. (NYSE: GG) $13.02 -4.4% 0.62%
Six of the 10 gold stocks listed above have posted negative returns so far in 2017. The main reason behind their losses has to do with gold price volatility.
- [By Alex McGuire]
This list shows the top-performing gold stocks this month, which we’ll be watching in September 2017. While these stocks posted gains in August, we still aren’t recommending them. Instead, we’re going to show you Money Morning Resource Specialist Peter Krauth’s pick for the best gold stock to buy this year…
Top Gold Stock Share Price August 2017 Gain
Sibanye Gold Ltd. (NYSE ADR: SBGL) $6.35 +22.9%
Iamgold Corp. (NYSE: IAG) $6.49 +20%
Alamos Gold Inc. (NYSE: AGI) $8.17 +15.1%
Franco Nevada Corp. (NYSE: FNV) $81.20 +11.6%
Hudbay Minerals Inc. (NYSE: HBM) $8.70 +11.5%
Gold Fields Ltd. (NYSE ADR: GFI) $4.42 +10.9%
Randgold Resources Ltd. (Nasdaq ADR: GOLD) $101.90 +9.6%
Harmony Gold Mining Co. (NYSE ADR: HMY) $1.97 +8.8%
Agnico Eagle Mines Ltd. (NYSE: AEM) $50.60 +8.4%
Yamana Gold Inc. (NYSE: AUY) $2.81 +7.9%
Life-Changing Profits: This investing strategy has racked up 30 triple-digit wins so far this year – and 46 in the last 12 months. To learn how to get in position for the next one, click here now…
- [By Ben Levisohn]
Deutsche Bank’s Jorge Beristain and Chris Terry released their earnings preview for the gold miners–including Barrick Gold (ABX), Goldcorp (GG), Franco-Nevada (FNV), and Coeur Mining (CDE)–and conclude that only one gold miner deserves a Buy rating: Newmont Mining (NEM). They explain why:
- [By David Zeiler]
“If you look back to the 70s, 80s and 90s, in every of those decades the industry found at least one 50+ million ounce gold deposit, at least ten 30+ million ounce deposits and countless five to 10 million ounce deposits. But if you look at the last 15 years, we found no 50 million ounce deposit, no 30 million ounce deposit and only very few 15 million ounce deposits,” Pierre Lassonde, chair of gold royalty and income stream company Franco-Nevada Corp. (NYSE: FNV), told German financial newspaper Finanz und Wirtschaft last October.
- [By Ben Levisohn]
Given revised commodity deck forecasts (particularly for Steel and Gold) and improved Balance Sheet health (Steels, Precious and Industrials Metals) we are upgrading our ratings on several stocks in our coverage. We generally favor companies that have already initiated specific self-help, have low-cost assets and are less exposed to China supply and demand dynamics. In Steels, we have increased our rating from Hold to Buy on Nucor (NUE) and from Sell to Hold on US Steel. We have also upgraded Kinross Gold (KGC) to a Hold on valuation…On higher-than-peer valuations, we reiterate Sell-rated Coeur Mining (CDE), Franco-Nevada (FNV), Goldcorp (GG), Teck Resources (TCK) and highly leveraged AK Steel given preference to issue further equity if possible.
Top Casino Stocks To Invest In Right Now: Centerra Gold Inc. (CAGDF)
- [By SEEKINGALPHA.COM]
The top news of the month goes to Centerra Gold (OTCPK:CAGDF), which agreed to buy Aurico Metals (OTCPK:ARCTF) for C$1.80 in cash, a 38.5% premium, at a value of C$310 million ($243 million).
- [By SEEKINGALPHA.COM]
Centerra Gold (OTCPK:CAGDF) bought out the previous owner of the Mt. Milligan Mine, Thompson Creek Metals, which really saved the asset for Royal Gold, as I explained in a past article. Mt. Milligan contributed $31.66 million of Royal Gold’s $106.9 million revenue this past quarter, or 29.6% of total revenue. I own shares of Centerra Gold, and I think Mt. Milligan is a strong asset that will contribute tons of cash flow for Royal Gold.